Non-Small Cell Lung Cancer Prognostic Role of the Cyclin-dependent Kinase Inhibitor p 27 in Updated

Despite its potential role as a tumor suppressor, p27 gene, a member of the Cip/Kip family of cydin-dependent kinase inhibitor genes, has never been found mutated in human tumors. We investigated p27 protein ex pression in a series of 108 non-small cell lung cancers (57.4% stage 1, 16.7% stage 2, and 25.9% stage 3) to determine whether the lack or altered expression of this protein correlates with neoplastic transforma don and/or progression. We performed immunohistochemistry and West em blotanalysisof eachspecimen.Wefoundthat tumorsexpressinglow to undetectable levels of p27 contained high p27 degradation activity. When we evaluated the outcome of the patients in relationship to p27 expression, we found p27 to be a prognostic factor correlating with the overall survival times (P = 0.0012). The possibility of a simple assay, such as the immunohistochemical analysis ofp27 expression on routinely formalin-fixed, paraffin-embedded specimens, has considerable value for the prognosis of patients who Un dergo surgical resection. In addition, confirmation of the involvement of the proteasome-mediated proteolysis in p27 degradation should stimulate new strategies of nonsurgical treatments of non-small cell lung cancer.

[1]  S. Spiro,et al.  Lung cancer: principles and practice , 2001, British Journal of Cancer.

[2]  M. Loda,et al.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.

[3]  W. Zwerschke,et al.  Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. , 1996, Oncogene.

[4]  A. Giordano,et al.  Retinoblastoma protein family in cell cycle and cancer: A review , 1996, Journal of cellular biochemistry.

[5]  K. Manova-Todorova,et al.  Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.

[6]  James M. Roberts,et al.  A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.

[7]  L. Hengst,et al.  Translational Control of p27Kip1 Accumulation During the Cell Cycle , 1996, Science.

[8]  T. Hunter,et al.  Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFβ-treated cells , 1996, Nature.

[9]  A. Marchetti,et al.  p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. , 1996, Oncogene.

[10]  S. Bohlander,et al.  Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. , 1996, Cancer research.

[11]  R. Hruban,et al.  p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. , 1995, The American journal of pathology.

[12]  C. Cordon-Cardo.  Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. , 1995, The American journal of pathology.

[13]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[14]  C. Bartram,et al.  Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. , 1995, Cancer research.

[15]  G. Condorelli,et al.  p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. , 1994, Cancer research.

[16]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[17]  James M. Roberts,et al.  Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.

[18]  James M. Roberts,et al.  Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family , 1991, Cell.

[19]  R. Smith,et al.  Epidemiology of lung cancer : Lung Cancer , 2000 .

[20]  P. Beer-Romero,et al.  Targeting Ubiquitin-Mediated Degradation for Proliferation Inhibitors , 1996 .

[21]  A. Giordano,et al.  Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. , 1995, Critical reviews in eukaryotic gene expression.

[22]  James M. Roberts,et al.  Tumor Suppression: Lessons in p16 from phylum Falconium , 1995, Current Biology.